-
$0
0.0% of portfolio
-
Q1 2024
Added 20.78%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 0.62%
$6.37M
$48,000
0.0% of portfolio
57,080
Q2 2024
Added 102.38%
$77.1M
$26,000
0.0% of portfolio
1,609
Q2 2024
Reduced 6.94%
$3.68M
$63,000
0.0% of portfolio
48,935
Q2 2024
Reduced 22.32%
$766M
$80 Million
0.0% of portfolio
2,963,583
Q2 2024
Added 5.21%
$506M
$79.3 Million
0.0% of portfolio
12,846,499
Q2 2024
Added 15.96%
$264M
$20.1 Million
0.0% of portfolio
5,459,808
Q2 2024
Added 140.18%
$1.44B
$103 Million
0.0% of portfolio
16,994,529
Q2 2024
Reduced 0.02%
-
$0
0.0% of portfolio
-
Q2 2024
Added 8.7%
$147M
$8.74 Million
0.0% of portfolio
2,974,478
Q2 2024
Added 7.49%
$172M
$8.49 Million
0.0% of portfolio
1,242,908
Q2 2024
Added 7.83%
$63.3B
$56.5 Million
0.0% of portfolio
3,296,651
Q2 2024
Added 5.14%
$963M
$82.2 Million
0.0% of portfolio
1,197,908
Q2 2024
Added 2.62%
-
$0
0.0% of portfolio
-
Q2 2024
New
$1.43B
$118 Million
0.0% of portfolio
6,442,710
Q2 2024
Added 3.28%
$150M
$7.17 Million
0.0% of portfolio
812,895
Q2 2024
Added 238.47%
$980M
$27.9 Million
0.0% of portfolio
1,879,853
Q2 2024
Added 3.15%
$536M
$6.32 Million
0.0% of portfolio
1,275,036
Q2 2024
Reduced 1.1%
$826M
$465,000
0.0% of portfolio
775,107
Q2 2024
Reduced 78.29%
$193M
$2.05 Million
0.0% of portfolio
341,021
Q2 2024
Reduced 9.04%
$413M
$10.6 Million
0.0% of portfolio
5,706,461
Q2 2024
Added 456.78%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 1.05%
$1.32B
$158 Million
0.0% of portfolio
9,629,359
Q2 2024
Reduced 5.06%
-
$0
0.0% of portfolio
-
Q3 2023
Added 10.0%
$204M
$67,000
0.0% of portfolio
72,718
Q2 2024
Reduced 90.93%
$273M
$13.3 Million
0.0% of portfolio
1,631,524
Q2 2024
Reduced 2.5%
$112M
$353,000
0.0% of portfolio
212,786
Q1 2024
Reduced 1.55%
Inovio Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 402.35%
$60.6M
$14.9 Million
0.0% of portfolio
3,343,193
Q2 2024
Added 8.24%
-
$0
0.0% of portfolio
-
Q2 2024
Added 21.43%
-
$0
0.0% of portfolio
-
Q2 2024
Added 11.53%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 1.48%
-
$0
0.0% of portfolio
-
Q4 2023
New
$253M
$14 Million
0.0% of portfolio
1,527,949
Q2 2024
Added 3.69%
$570M
$104 Million
0.0% of portfolio
3,354,093
Q2 2024
Added 0.55%
-
$0
0.0% of portfolio
-
Q1 2024
Added 62.28%
$3.35B
$34.5 Million
0.0% of portfolio
1,471,597
Q2 2024
Added 12.77%
-
$0
0.0% of portfolio
-
Q2 2024
Added 3.41%
$4.57B
$127 Million
0.0% of portfolio
3,456,628
Q2 2024
Added 2.1%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 7.89%
Integra Lifesciences Hldgs C
-
$0
0.0% of portfolio
-
Q1 2024
Added 10.08%
-
$0
0.0% of portfolio
-
Q2 2023
New
$1.64B
$57.4 Million
0.0% of portfolio
5,907,182
Q2 2024
Added 8.72%
$799M
$215 Million
0.0% of portfolio
9,597,607
Q2 2024
Added 5.36%
$52.6M
$339,000
0.0% of portfolio
99,134
Q2 2024
Added 123.14%
Intensity Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 29.64%
$24B
$24.3 Million
0.0% of portfolio
229,362
Q2 2024
Added 6.84%
$3.43B
$14.2 Million
0.0% of portfolio
635,314
Q2 2024
Added 79.03%
$75.4M
$48,000
0.0% of portfolio
24,162
Q4 2022
Added 86.45%